Cangrelor to optimise platelet inhibition in STEMI patients pre-treated with ticagrelor: A Sisyphean task?

Int J Cardiol Heart Vasc · 2024 · PMC10899725 · PMID 38419607

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

This difference was apparent only at 1 h after administration, with comparable platelet inhibition in the two groups at 2,4 and 8 h.

also in 205 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.